GSK plc (LON:GSK)
1,823.50
-1.00 (-0.05%)
Nov 12, 2025, 4:53 PM BST
GSK plc Market Cap
GSK plc has a market cap or net worth of 73.31 billion as of November 12, 2025. Its market cap has increased by 29.04% in one year.
Market Cap
73.31B
Enterprise Value
87.36B
Revenue
32.17B
Ranking
n/a
PE Ratio
13.73
Stock Price
1,823.50
Market Cap Chart
Since December 27, 2000, GSK plc's market cap has increased from 64.68B to 73.31B, an increase of 13.35%. That is a compound annual growth rate of 0.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2025 | 73.27B | 33.36% |
| Dec 31, 2024 | 54.94B | -7.05% |
| Dec 29, 2023 | 59.11B | 1.25% |
| Dec 30, 2022 | 58.38B | -27.44% |
| Dec 31, 2021 | 80.46B | 20.44% |
| Dec 31, 2020 | 66.80B | -24.13% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 200.04B |
| Haleon | 32.17B |
| Smith & Nephew | 10.74B |
| ConvaTec Group | 4.68B |
| Hikma Pharmaceuticals | 3.50B |
| HUTCHMED (China) | 2.03B |
| Genus | 1.58B |
| Oxford Nanopore Technologies | 1.35B |